Dr. Rodrigo González Barrios de la Parra
Investigador del Instituto Nacional de Cancerología (INCan) y jefe de grupo del Laboratorio de Regulación de la Cromatina y Genómica (CromGenLab). Su trabajo une la regulación de la cromatina y la epigenética del cáncer con la búsqueda de biomarcadores en cáncer de testículo a través de la plataforma TESTINCan.

Cargos
- Jefe de Grupo, Laboratorio de Regulación de la Cromatina y Genómica, INCan
- Investigador en Ciencias Médicas “D”, Instituto Nacional de Cancerología
- Sistema Nacional de Investigadores, nivel II
- Profesor de la Facultad de Ciencias, UNAM
Formación
- Doctorado en Ciencias Biomédicas, Instituto de Investigaciones Biomédicas, UNAM
- Licenciatura en Biología, Facultad de Ciencias, UNAM
Redes y consorcios
- Miembro del Testicular Cancer Consortium (TECAC)
- Miembro fundador de la Red de Epigenómica Mexicana
Investigación
Contacto
rodrigop@ciencias.unam.mx · Instituto Nacional de Cancerología, Ciudad de México
Publicaciones recientes
- 2026
Uncovering novel germline variants associated with testicular germ cell tumors by exome sequencing
Cuevas-Estrada B, Ríos-Rodríguez JA, García-Pacheco JA, Wegman-Ostrosky T, Cervera A, Alcaraz N, Montalvo-Casimiro M, Barrón-Hernández A, Castro-Hernández C, Jiménez-Ríos MA, Sobrevilla-Moreno N, Arriaga-Canon C, Herrera LA, González-Barrios R*.
NAR Cancer · 8(2):zcag007 · 2026
DOI: 10.1093/narcan/zcag007PubMed 42017013PMC13092976
Relación con el laboratorio: Línea III · Firmas moleculares en TCGT
- 2026
Metabolic profile and skeletal muscle as predictors of survival in testicular germ cell tumors
Barrón-Hernández A, Ríos-Rodríguez JA, García-Pacheco JA, Cuevas-Estrada B, De-la-Rosa S, Castro-Hernández C, Jiménez-Ríos MA, Sobrevilla-Moreno N, Santibáñez-Andrade M, González-Barrios R*.
The Oncologist · 31(5):oyag072 · 2026
DOI: 10.1093/oncolo/oyag072PMC13092131
Relación con el laboratorio: TESTINCan · Composición corporal y metabolismo
- 2025
Palmitic acid induces dynamic time-dependent alterations in HDACs, neuronal chromatin acetylation, and gene expression
Rueda-Díaz SS, Soto-Santarriaga IF, Torres-Arciga K, García-Cruz VM, González-Barrios R, Flores-León M, Arias C.
Neurochemical Research · 50(4):220 · 2025
DOI: 10.1007/s11064-025-04469-wPubMed 40586999
Relación con el laboratorio: Línea I · Remodelación epigenética de la cromatina
- 2025
Retrotransposon expression is upregulated in adulthood and suppressed during regeneration of the limb in the axolotl (Ambystoma mexicanum)
Ruiz-Pérez S, Alcaraz N, Torres-Arciga K, Ocampo-Cervantes JA, Cervera A, Castro-Hernández C, Sámano-Salazar CG, Soto-Reyes E, González-Barrios R*.
Advanced Biology · e00502 · 2025
DOI: 10.1002/adbi.202400502PubMed 40443108
Relación con el laboratorio: Colaboración · Regeneración en ajolote
- 2025
Founder variants in the Mexican population: a systematic review
Harari-Arakindji S, Metta-Harari T, Espino-Gutiérrez I, Taja-Chayeb L, González-Barrios R, Zatarain-Barrón ZL, García-Ortiz JE, Wegman-Ostrosky T.
Archives of Medical Research · 56(5):103209 · 2025
DOI: 10.1016/j.arcmed.2025.103209PubMed 40233595
Relación con el laboratorio: Genómica de la población mexicana
- 2024
Underlying mechanisms of the protective effects of lifestyle factors on age-related diseases
Alcaraz N, Salcedo-Tello P, González-Barrios R, Torres-Arciga K, Guzmán-Ramos K.
Archives of Medical Research · 55:103014 · 2024
Relación con el laboratorio: Colaboración · Epigenética, ambiente y envejecimiento
- 2024
Key proteins for regeneration in A. mexicanum: transcriptomic insights from aged and juvenile limbs
Del Moral-Morales A, Sámano C, Ocampo-Cervantes JA, Topf M, Baumbach J, Hernández J, Torres-Arciga K, González-Barrios R*, Soto-Reyes E*.
Scientifica · 2024:5460694 · 2024
DOI: 10.1155/2024/5460694PMC11581807
Relación con el laboratorio: Colaboración · Regeneración en ajolote
- 2024
A molecular characterization of the allelic expression of the BRCA1 founder Δ9–12 pathogenic variant and its potential clinical relevance in hereditary cancer
Domínguez-Ortiz J, Álvarez-Gómez RM, Montiel-Manríquez R, Cedro-Tanda A, Alcaraz N, Castro-Hernández C, Bautista-Hinojosa L, Contreras-Espinosa L, Torres-Maldonado L, Fragoso V, Sánchez Y, González-Barrios R, De la Fuente M, Mejía ML, Juárez-Figueroa U, Padua A, Sosa-León R, Nicasio-Arzeta S, Rodríguez A, Luna F, Cisneros-Soberanis F, Frías S, Arriaga-Canon C, Herrera-Montalvo LA.
International Journal of Molecular Sciences · 25(12):6773 · 2024
DOI: 10.3390/ijms25126773PMC11204022
Relación con el laboratorio: Genómica del cáncer hereditario
Publicaciones anteriores
Artículos originales 22
- 2023
Understanding sociodemographic factors among Hispanics through a population-based study on testicular cancer in Mexico
Ríos-Rodríguez JA, Montalvo-Casimiro M, Álvarez-López DI, Reynoso-Noverón N, Cuevas-Estrada B, Mendoza-Pérez J, Jiménez-Ríos MA, Wegman-Ostrosky T, Salcedo-Tello P, Scavuzzo A, Castro-Hernández C, Herrera LA, González-Barrios R*.
Journal of Racial and Ethnic Health Disparities · 2023
- 2022
Deep DNA sequencing of MGMT, TP53 and AGT in Mexican astrocytoma patients identifies an excess of genetic variants in women and a predictive biomarker
Carlos-Escalante JA, Mejía-Pérez SI, Soto-Reyes E, Guerra-Calderas L, Cacho-Díaz B, Torres-Arciga K, Montalvo-Casimiro M, González-Barrios R, … Herrera LA, Corona T, Wegman-Ostrosky T.
Journal of Neuro-Oncology · 2022
- 2022
Genomic profile in a non-seminoma testicular germ-cell tumor cohort reveals a potential biomarker of sensitivity to platinum-based therapy
González-Barrios R, Alcaraz N, Montalvo-Casimiro M, Cervera A, Arriaga-Canon C, Munguía-Garza P, Hinojosa-Ugarte D, Sobrevilla-Moreno N, Torres-Arciga K, Mendoza-Pérez J, Díaz-Chávez J, Cortés-González CC, Castro-Hernández C, Martínez-Cedillo J, Scavuzzo A, Pérez-Montiel D, Jiménez-Ríos MA, Herrera LA.
Cancers (Basel) 14(9):2065 · 2022
- 2022
CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy
Salgado-Albarrán M, Späth J, González-Barrios R, Baumbach J, Soto-Reyes E.
NPJ Systems Biology and Applications 8(1):5 · 2022
- 2022
Large-scale topological disruption of chromosome territories 9 and 22 is associated with nonresponse to treatment in CML
Fabián-Morales E, Vallejo-Escamilla D, Gudiño A, Rodríguez A, González-Barrios R, … Frías S, Herrera LA.
International Journal of Cancer 150(9):1455–1470 · 2022
- 2022
Proteasome inhibition alters mitotic progression through the upregulation of centromeric α-satellite RNAs
Cáceres-Gutiérrez RE, Andonegui MA, Oliva-Rico DA, González-Barrios R, … Francastel C, Herrera LA.
FEBS Journal 289(7):1858–1875 · 2022
- 2021
Transcriptome analysis identifies GATA3-AS1 as a long noncoding RNA associated with resistance to neoadjuvant chemotherapy in locally advanced breast cancer patients
Contreras-Espinosa L, Alcaraz N, De La Rosa-Velázquez IA, … González-Barrios R, … Arriaga-Canon C, Herrera LA.
Journal of Molecular Diagnostics · 2021
- 2021
Transcriptional profiles reveal deregulation of lipid metabolism and inflammatory pathways in neurons exposed to palmitic acid
Flores-León M, Alcaraz N, Pérez-Domínguez M, Torres-Arciga K, Rebollar-Vega R, De la Rosa-Velázquez IA, Arriaga-Canon C, Herrera LA, Arias C*, González-Barrios R*.
Molecular Neurobiology · 2021
- 2021
Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection
Salgado-Albarrán M, Navarro-Delgado EI, Del Moral-Morales A, Alcaraz N, Baumbach J, González-Barrios R*, Soto-Reyes E*.
npj Systems Biology and Applications · 2021
- 2021
Saliva is a reliable and accessible source for the detection of SARS-CoV-2
Herrera LA, Hidalgo-Miranda A, Reynoso-Noverón N, Meneses-García A, Mendoza-Vargas A, … González-Barrios R, et al.
International Journal of Infectious Diseases · 2021
- 2020
Sex-dependent pronociceptive role of spinal α5-GABAA receptor and its epigenetic regulation in neuropathic rodents
Franco-Enzástiga Ú, García G, Murbartián J, González-Barrios R, … Price TJ, Granados-Soto V.
Journal of Neurochemistry · 2020
- 2020
Landscape of germline genetic variants in AGT, MGMT, and TP53 in Mexican adult patients with astrocytoma
Carlos-Escalante JA, Gómez-Flores-Ramos L, Bian X, Perdomo-Pantoja A, de Andrade KC, Mejía-Pérez SI, Cacho-Díaz B, González-Barrios R, et al.
Cellular and Molecular Neurobiology · 2020
- 2019
The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer
Salgado-Albarrán M, González-Barrios R, Guerra-Calderas L, Alcaraz N, Sánchez-Correa TE, … Herrera LA, Baumbach J, Soto-Reyes E.
Oncogenesis 8:41 · 2019
- 2019
Histamine modulates midbrain dopamine neuron differentiation through the regulation of epigenetic marks
Vargas-Romero F, González-Barrios R, Guerra-Calderas L, Escobedo-Ávila I, Cortés-Pérez D, López-Ornelas A, Rocha L, Soto-Reyes E, Velasco I.
Frontiers in Cellular Neuroscience 13:215 · 2019
- 2019
Palmitic acid-induced NAD+ depletion is associated with the reduced function of SIRT1 and increased expression of BACE1 in hippocampal neurons
Flores-León M, Pérez-Domínguez M, González-Barrios R, Arias C.
Neurochemical Research 44(7):1747–1754 · 2019
- 2018
CTCF-KDM4A complex correlates with histone modifications that negatively regulate CHD5 gene expression in cancer cell lines
Guerra-Calderas L*, González-Barrios R*, Patiño C, Alcaraz N, Salgado-Albarrán M, Cantú de León D, et al.
Oncotarget 9:17028–17042 · 2018
- 2016
MAD2γ, a novel MAD2 isoform, reduces mitotic arrest and is associated with resistance in testicular germ cell tumors
López-Saavedra A, Ramírez-Otero M, Díaz-Chávez J, Cáceres-Gutiérrez R, Justo-Garrido M, Andonegui MA, Mendoza J, Downie-Ruíz Á, Cortés-González C, Reynoso N, Castro C, Domínguez-Gómez G, Santibáñez-Andrade M, Fabián-Morales E, Pruefer F, Luna-Maldonado F, González-Barrios R, Herrera LA.
Cell Cycle · 2016
- 2016
Methylation of DAPK and THBS1 genes in esophageal gastric-type columnar metaplasia
Herrera-Goepfert R, Oñate-Ocaña LF, Mosqueda-Vargas JL, Herrera LA, Castro C, Mendoza J, González-Barrios R.
World Journal of Gastroenterology 22(18):4567–4575 · 2016
- 2014
Differential distribution of HP1 proteins after trichostatin A treatment influences chromosomal stability in HCT116 and WI-38 cells
González-Barrios R, Soto-Reyes E, Quiroz-Báez R, Fabián-Morales E, Díaz-Chávez J, del Castillo V, Mendoza J, López-Saavedra A, Castro C, Herrera LA.
Cell Division 9:6 · 2014
- 2013
Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours
Mendoza J, Martínez J, Hernández C, Pérez-Montiel D, Castro C, Fabián-Morales E, Santibañez M, González-Barrios R, Díaz-Chávez J, Andonegui MA, Reynoso N, Oñate LF, Jiménez MA, Núñez M, Dyer R, Herrera LA.
British Journal of Cancer 109(1):68–75 · 2013
- 2012
Satellite 2 demethylation induced by 5-azacytidine is associated with missegregation of chromosomes 1 and 16 in human somatic cells
Prada D, González-Barrios R, Sánchez L, Castro C, Fabián E, Herrera LA.
Mutation Research 729(1–2):100–105 · 2012
- 2012
Disruption of CTCF at the miR-125b1 locus in gynecological cancers
Soto-Reyes E, González-Barrios R, Prada D, Cisneros-Soberanis F, Herrera-Goepfert R, Pérez V, Cantú D, Castro C, Recillas-Targa F, Herrera LA.
BMC Cancer 12:40 · 2012
Artículos de revisión 9
- 2023
Breaking the mold: epigenetics and genomics approaches addressing novel treatments and chemoresponse in TGCT patients
Cuevas-Estrada B, Montalvo-Casimiro M, Munguía-Garza P, Ríos-Rodríguez JA, González-Barrios R*, Herrera LA.
International Journal of Molecular Sciences 24(9):7873 · 2023
- 2022
Histones and their chaperones: adaptive remodelers of an ever-changing chromatinic landscape
Torres-Arciga K, Flores-León M, Ruiz-Pérez S, Trujillo-Pineda M, González-Barrios R*, Herrera LA.
Frontiers in Genetics 13:1057846 · 2022
- 2022
The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches
Alarcón-Zendejas AP, Scavuzzo A, Jiménez-Ríos MA, … González-Barrios R, Jiménez-Trejo F, Arriaga-Canon C, Herrera LA.
Prostate Cancer and Prostatic Diseases · 2022
- 2021
Genomics and epigenomics of axolotl regeneration
Sámano C, González-Barrios R, Castro-Azpíroz M, Torres-García D, Ocampo-Cervantes JA, Otero-Negrete J, Soto-Reyes E.
International Journal of Developmental Biology · 2021
- 2020
Epidrug repurposing: discovering new faces of old acquaintances in cancer therapy
Montalvo-Casimiro M*, González-Barrios R*, Meraz-Rodríguez MA, Juárez-González VT, Arriaga-Canon C, Herrera LA.
Frontiers in Oncology 10:605386 · 2020
- 2020
The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics
Bautista-Sánchez D, Arriaga-Canon C, Pedroza-Torres A, De La Rosa-Velázquez IA, González-Barrios R, … Herrera LA.
Molecular Therapy – Nucleic Acids 20:409–420 · 2020
- 2018
The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer
Arriaga-Canon C, De la Rosa I, González-Barrios R, Montiel-Manríquez R, Oliva-Rico D, Jiménez-Trejo F, Cortés-González C, Herrera LA.
Oncotarget · 2018
- 2014
The role of the histone demethylase KDM4A in cancer
Guerra-Calderas L, González-Barrios R, Herrera LA, Cantú de León D, Soto-Reyes E.
Cancer Genetics · 2014
- 2012
Assembling pieces of the centromere epigenetics puzzle
González-Barrios R, Soto-Reyes E, Herrera LA.
Epigenetics 7(1) · 2012
Capítulos de libro 3
- 2021
Bioinformatics of transcription factor binding prediction
Navarro-Delgado EI, Salgado-Albarrán M, Torres-Arciga K, Alcaraz N, Soto-Reyes E, Herrera LA, González-Barrios R.
En: Forero DA (ed.), Bioinformatics and Human Genomics Research. CRC Press · 2021
- 2019
Epigenetic data and disease
González-Barrios R, Salgado-Albarrán M, Alcaraz N, Arriaga-Canon C, Guerra-Calderas L, Contreras-Espinosa L, Soto-Reyes E.
En: Analyzing Network Data in Biology and Medicine. Cambridge University Press · 2019
- 2017
Cáncer de ovario: una nueva visión integral
Soto-Reyes E, González-Barrios R, Cantú de León D.
En: Biología Molecular y Genómica del Cáncer. PyDESA, México · 2017